Groundbreaking research challenges traditional neurodivergent diagnoses

A new article introduces a dimensional approach to understanding the mental health needs of neurodivergent people.

IG Live March 29: Maternal Mortality Remains ‘Unacceptably High’

Despite being a high-income country, the U.S. has double the maternal death rate of most other developed nations, with racial disparities exacerbating the crisis. In

March 29, 2024

FDA approves Sarepta’s Duchenne gene therapy for nearly all patients

The Food and Drug Administration on Thursday approved Elevidys, Sarepta’s gene therapy for Duchenne muscular dystrophy, for nearly all patients with the fatal muscle-wasting disease,

June 20, 2024

Study uncovers how OTX2 drives aggressive childhood brain cancer

In a report published in Nature Cell Biology, researchers at Baylor College of Medicine, Texas Children’s Hospital, the University of Manitoba and collaborating institutions revealed

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.